New Delhi, July 28: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 3,845 new medicines, a move aimed at improving transparency and ensuring greater affordability for patients.
The government said the price regulation initiative is part of ongoing efforts to make essential medicines more accessible while maintaining a balanced approach for the pharmaceutical industry.
The decision will help bring clarity to medicine pricing and support patients by ensuring regulated rates for a wide range of medicines.
Officials said the government continues to monitor the pharmaceutical market and take measures to promote affordable healthcare and protect consumer interests.
The latest step highlights the focus on strengthening India’s healthcare system by improving access to quality medicines at reasonable prices.
